Financials data is unavailable for this security.
View more
Year on year SMS Lifesciences India Ltd 's revenues fell -3.04% from 3.16bn to 3.06bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 114.63m to 90.93m, a -20.68% decrease.
| Gross margin | 34.82% |
|---|---|
| Net profit margin | 5.33% |
| Operating margin | 9.23% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at SMS Lifesciences India Ltd fell by 7.08m. However, the company earned 243.06m from its operations for a Cash Flow Margin of 7.94%. In addition the company used 184.50m on investing activities and also paid 65.64m in financing cash flows.
| Cash flow per share | 106.35 |
|---|---|
| Price/Cash flow per share | 13.99 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -20.68%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
| Div yield(5 year avg) | 0.21% |
|---|---|
| Div growth rate (5 year) | 0.00% |
| Payout ratio (TTM) | 2.54% |
| EPS growth(5 years) | -12.62 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 153.68 |
More ▼
